Celsior solution for organ preservation
Authorisation PA1996/001/001 · Institut Georges Lopez - IGL
- Licence holder
- Institut Georges Lopez - IGL (all products →)
- Active substances
- Glutathione, Mannitol, Lactobionic acid, Glutamic acid, Sodium hydroxide, Calcium chloride 2 h2o, Potassium chloride, Magnesium chloride 6 h2o, Histidine
- Clinical trials
- 2 clinical trials → 10 clinical trials → 3 clinical trials →
- Dosage form
- Solution for organ preservation
- Route of administration
- Extracorporeal use
- ATC code
- V07AB
- First authorised
- 01/04/2011
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Known active substance (Article 8(3) of Directive No 2001/83/EC)
Glutathione: supply and approvals
1 authorised product on the HPRA list contains Glutathione. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 18 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 18 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 18 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Mannitol: supply and approvals
4 authorised products on the HPRA list contain Mannitol. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- Bronchitol: Shortage ongoing, first published 14 Nov 2025
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 18 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 18 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Lactobionic acid: supply and approvals
1 authorised product on the HPRA list contains Lactobionic acid. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 18 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 18 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 18 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 15 years (since 1 April 2011). The HPRA list marks it as marketed in Ireland.
Other medicines with Glutathione in Ireland
No other product on the HPRA list contains Glutathione.
Other medicines with Mannitol in Ireland
3 other products on the HPRA list contain Mannitol, from 2 licence holders; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Mannitol 10% Solution for Infusion BP | Baxter Holding B.V. | National authorisation (PA) | Marketed |
| Osmohale, inhalation powder, hard capsule | Pharmaxis Europe Limited | National authorisation (PA) | Marketed |
| Bronchitol 40 mg inhalation powder, hard capsules | Pharmaxis Europe Limited | Centralised EU authorisation | Not stated |
Other substances in ATC group V07AB
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 4 other active substances share the group V07AB with this product:
Water for injections (3) · Sodium chloride (2) · Glucose (1) · Water for injection (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.